Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Rituximab may cause skin issues, but baricitinib can help improve them.

Possible new treatments for common hair loss include drugs, stem cells, and improved transplants.

New and repurposed treatments are improving outcomes in dermatology.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Itraconazole helps improve tough skin infections but may not prevent them from coming back.

Some drugs may help treat both COVID-19 and radiation injury.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

New compounds may help treat prostate issues without affecting androgen receptors.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

New treatments for alcohol, opioid, and cannabis addiction include medications, therapy, and personalized plans.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

All-trans-retinoic acid stops mink hair growth by affecting cell growth and causing cell death.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

Prostate cancer prevention now focuses on healthy diets and some medications, not vitamins.

Abatacept may help some people with alopecia areata regrow hair.

The new microneedle patch effectively treats alopecia areata with fewer side effects than oral medication.

Azathioprine can help with relapses and disability in NMOSD but has more side effects and needs more research.

Relapsing hepatitis A can cause prolonged abnormal liver tests even without symptoms.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Intralesional corticosteroids and 5-alpha-reductase inhibitors are the best treatments for frontal fibrosing alopecia.

New drug uses show promise but need more research.

The FDA did not approve a testosterone drug because of safety concerns.

Certain medications can help treat PCOS symptoms, but they aren't FDA-approved for this use.

Cepharanthine may help treat Equid herpesvirus type 8 by reducing oxidative stress.

The model successfully predicted new uses for existing drugs, like using certain hormonal and heart medications for respiratory and Parkinson's diseases, and a cancer drug for diabetes.